Press release
20th Euro Congress on Psychiatrists and Psychologists
Submit your abstract
Description: Euro Psychiatrists 2017 (CME Accredited Event) will provide an opportunity for all stakeholders working on mental health issues to talk about their work. Euro Psychiatrists 2017 will congregate renowned speakers, principal investigators, experts, psychiatrist and researchers from both academia and health care industry will join together to discuss their views and research.
Conference highlights
1. Psychiatry
2. Psychology
3. Child and Adolescent Psychology
4. Psychosis And Adverse Behavior
5. Schizophrenia and Bipolar Disorder
6. Dissociative and Addictive Disorders
7. Personality Disorders
8. Psychooncology
9. Neuropsychology and brain/behavioral disorders
10. Recovery and Psychotherapy
11. Mental health and Psychiatric Complications
12. Post-Traumatic Stress Disorder
13. Psychoactive Medication
14. Geriatric Psychiatry
15. Forensic and Emergency Psychiatry
16. Psychiatric Nursing
17. Advanced Therapeutics For Psychiatric Disorders
18. Entrepreneurs Investment Meet
conference series LLC
5716 Corsa Ave., Suite110, Westlake, Los Angeles, CA 91362-7354, USA; Tel: +1-650-268-9744, Fax: +1-650-618-1414
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 20th Euro Congress on Psychiatrists and Psychologists here
News-ID: 412539 • Views: …
More Releases from ConferenceseriesLLC
34th Oncology Nursing & Nurse Practitioners Conference
Connect with 300+ Global Speakers and Experts @ Nursing Education Conferences | Oncology Nursing Conferences | Nursing Continuing Education Conferences
Conference Series LLC takes immense pleasure & feels honoured in inviting the contributors across the globe to attend the “34th Oncology Nursing & Nurse Practitioners Conference” which will be held in August 28-30, 2017 at Philadelphia, USA.
Target Spectators: We extend warm welcome to distinguished Speakers, Delegates,…
More Releases for Disorder
Rising Mental Disorder Cases Drive Expansion Of The Generalized Anxiety Disorder …
The Generalized Anxiety Disorder Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Generalized Anxiety Disorder Market Size and Projected Growth Rate?
The market size for generalized anxiety disorder has seen a stable growth in the past few years. The market is expected to…
Autism Spectrum Disorder Therapeutics Market: "Autism Spectrum Disorder Therapie …
Autism Spectrum Disorder Therapeutics Market Scope:
Key Insights : Autism Spectrum Disorder Therapeutics Market size was valued at USD 1.92 billion in 2022 and is poised to grow from USD 2.07 billion in 2023 to USD 3.77 billion by 2031, growing at a CAGR of 7.80% during the forecast period (2024-2031).
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/autism-spectrum-disorder-therapeutics-market
In-Depth Exploration of the global Autism Spectrum Disorder Therapeutics …
Bipolar Disorder Therapeutics Market Report 2024 - Bipolar Disorder Market Oppor …
"The Business Research Company recently released a comprehensive report on the Global Bipolar Disorder Therapeutics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
Bipolar Disorder Therapeutics Market: Balancing the Mind - Unveiling Breakthroug …
Allied Market Research recently said Bipolar disorder, a mental health condition characterized by extreme shifts in mood and energy levels, affects millions of people worldwide. The quest for effective therapeutics to manage this complex disorder has seen remarkable progress in recent years. This article explores the innovative developments in bipolar disorder therapeutics, shedding light on the path to achieving a harmonious balance for those living with this condition.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞…
Anti-Depressant Drugs Market to 2027 - Global Analysis and Forecasts By Depressi …
Anti-depressant drugs is a class of medications which is used to treat major depressive disorder, some anxiety disorders, some chronic pain conditions, and to help manage some addictions. Anti-depressant drugs also reduce symptoms of depressive disorders by correcting chemical imbalances of neurotransmitters in the brain. Chemical imbalances may be responsible for changes in mood and behavior.
Anti-depressant drugs market is anticipated to grow in the forecast period owing to driving factors…
Antidepressant Drugs Market Report 2018: Segmentation by Depressive Disorder (Ma …
Global Antidepressant Drugs market research report provides company profile for Alkermes Plc, Allergan Plc, Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms…
